Treace Medical Concepts (TMCI) Non-Current Debt (2020 - 2026)

Treace Medical Concepts has reported Non-Current Debt for 7 years, with the latest figure at $55.8 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Debt rose 4.57% year-over-year to $55.8 million; the trailing twelve-month figure through Mar 2026 stood at $55.8 million (up 4.57% YoY), and the FY2025 full-year result was $55.6 million, up 4.27% from the prior year.
• Non-Current Debt for Q1 2026 stood at $55.8 million, roughly flat from $55.6 million in the prior quarter.
• The five-year high for Non-Current Debt was $55.8 million in Q1 2026, with the low at $29.4 million in Q1 2022.
• Historically, Non-Current Debt has averaged $52.0 million across 5 years, with a median of $53.1 million in 2024.
• Annual changes were most pronounced in 2022 — Non-Current Debt surged 79.53% — and 2025, when it grew 0.56%.
• Treace Medical Concepts' Non-Current Debt stood at $52.7 million in 2022, then rose by 0.56% to $53.0 million in 2023, then rose by 0.56% to $53.3 million in 2024, then advanced by 4.27% to $55.6 million in 2025, then rose by 0.43% to $55.8 million in 2026.
• The last three Non-Current Debt figures came in at $55.8 million (Q1 2026), $55.6 million (Q4 2025), and $53.5 million (Q3 2025), per Business Quant data.